The autoimmune regulator AIRE in thymoma biology: Autoimmunity and beyond

84Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Thymomas are tumors of thymic epithelial cells. They associate more often than any other human tumors with various autoimmune diseases; myasthenia gravis is the commonest, occurring in 10-50% of thymoma patients, depending on the World Health Organization-defined histologic subtype. Most thymomas generate many polyclonal maturing T lymphocytes but in disorganized microenvironments Failure to induce self-tolerance may be a key factor leading to the export of potentially autoreactive CD4 progeny, thus predisposing to autoimmune diseases. Normally, the master Autoimmune Regulator promotes expression of peripheral tissue-restricted antigens such as insulin by medullary thymic epithelial cells and induction of tolerance to them. The failure of ∼95% of thymomas to express autoimmune regulator is another feature potentially contributing to autoimmunity. © 2010 by the International Association for the Study of Lung Cancer.

Cite

CITATION STYLE

APA

Marx, A., Hohenberger, P., Hoffmann, H., Pfannschmidt, J., Schnabel, P., Hofmann, H. S., … Ströbel, P. (2010). The autoimmune regulator AIRE in thymoma biology: Autoimmunity and beyond. Journal of Thoracic Oncology, 5(10 SUPPL. 4). https://doi.org/10.1097/JTO.0b013e3181f1f63f

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free